Healthcare
Sonic Healthcare Limited(SKHCF)
Live Price
Offline$12.00
+0.00% today
1Y Change
-25.40%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $9.86B
- Revenue Growth
- +8.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 5.4%
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sonic Healthcare Limited (SKHCF) is a Healthcare stock with a market cap of $9.86B and listed on OTC. The stock last traded around $12.00 and down 25.4% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +8.0%, EPS growth of 0.0%, a dividend yield of 5.4%. What stands out right now is revenue +8.0%, EPS 0.0%, free cash flow +95.2% with operating margin 19.0% and ROIC 9.3%. The dividend matters to the case here, with a current yield around 5.4%. Valuation is more restrained than many high-expectation growth names at P/E 18.3 and price/sales 0.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SKHCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+8.0% vs +7.6% peer median
Operating Margin
Near sector median
+19.0% vs +19.4% peer median
P/E
Below sector median
18.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Feb 18, 2026 with an EPS surprise of -5.2% and a revenue surprise of -0.6%.
The setup is mixed rather than one-directional
Revenue is +8.0% and EPS is 0.0%, while operating margin sits near 19.0%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 20, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.6% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 18, 2026 | -5.2% | +6.7% | +6.7% | +0.0% |
2025 Aug 20, 2025 | -3.6% | -9.8% | -16.5% | -20.4% |
2025 Feb 18, 2025 | -3.1% | +0.0% | +2.0% | +8.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKHCF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SKHCF Max Drawdown
-37.95%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SKHCF and SPY.
Company Overview
Sonic Healthcare Limited
Other OTC
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
- Leadership
- James Pacey Newcombe
- IPO Date
- Jun 9, 2010
- Employees
- 42.0k
- Street Address
- Grosvenor Place
- Mailing
- Sydney, NSW, 2000
- Region
- Sydney, NSW, AU
- Reporting Currency
- USD
- Investor Line
- 61 2 9855 5444
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 18.3
- EV/EBITDA
- 13.4
- Price/Sales
- 0.9
- Price/Book
- 1.2
Growth
- Revenue
- +8.0%
- EPS
- 0.0%
- Free Cash Flow
- +95.2%
Profitability
- Gross Margin
- 29.6%
- Operating Margin
- 19.0%
- Net Margin
- 5.2%
- ROE
- 6.4%
- ROIC
- 9.3%
Balance Sheet
- Debt/Equity
- 0.86
- Current Ratio
- 1.01
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.